Clinical Trials Browser

Phase 1 × Lymphoma, B-Cell × zanubrutinib × Clear all

NCT06824701 2026-04-06

TARZAN

Phase 1 Suspended

Recurrence, Lymphoma, B-Cell

NCT03189524 2024-12-27

A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma

Phase 1 Completed

44 enrolled 27 charts

Lymphoma, B-Cell